Episode
Takeda and Insilico Team Up on AI Drugs | Tech News
- Published
- Jul 3, 2026
- Duration seconds
- 120
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/tech-news-today-2-min-news-the-daily-news-now-7438584/episodes/takeda-and-insilico-team-up-on-ai-drugs-tech-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/tech-news-today-2-min-news-the-daily-news-now-7438584/takeda-and-insilico-team-up-on-ai-drugs-tech-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Takeda teams up with Insilico Medicine to supercharge drug discovery using AI, granting exclusive rights to new medicines while Insilico handles AI-driven target identification and molecule design. This marks Takeda’s latest leap into AI-powered research, following a similar cancer-focused deal with Iambic. Insilico, already in clinical trials with an AI-generated lung drug and backed by major partners like Eli Lilly and SK Biopharmaceuticals, sees its stock soar after the announcement — signaling a bold industry shift toward AI to accelerate next-gen treatments. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/86f928b8f3617612